AUG 15, 2018 01:35 AM PDT

Experimental Drug May Treat The Chronic Itch

WRITTEN BY: Nouran Amin

Investigators at the University of Zurich have discovered a new approach that treats the chronic itch thanks to two receptors in the spinal cord and the right experimental drug.

Through a series of experiments in animal models, researchers were successful in alleviating different forms of acute as well as chronic itch. The drug serves especially useful for treating chronic itch since current treatment options are limited.

Itching can occur from many factors. For one, itching can be caused by the unpleasant feeling of being bitten by a mosquito. This type of itch is luckily treated by multiple OTC drugs as well as prescriptions. However, these particular drugs cannot effectively treat the debilitating itch that is caused by patients suffering from skin, kidney, or liver diseases. This particular chronic itch condition, affecting roughly 10 percent of the population, is currently managed with antidepressants or immune suppressants. Once again, these drugs were created to treat other diseases but often fail to be effective in providing the desired relief or come with negative side effects.

Image Retrieved From Unsplash, www.unsplash.com

Hanns Ulrich Zeilhofer, a professor at the Institute of Pharmacology and Toxicology of the University of Zurich, and his research team have now discovered a new way to alleviate the itching sensation. The researchers used an experimental drug to boost the effect of certain neurons present in the spine that block the itch signals from being sent to the brain. The scientists had also previously pinned and described these particular neurons three years ago. Since then, genetic mouse models were used to identify two specific receptors that control the effect of the spinal neurons. These receptors are considered part of a larger group of receptors that are activated by the amino acid transmitter gamma-aminobutyric acid, or GABA. Furthermore, the studied experimental drug was originally developed to treat anxiety through interactions with the two identified receptors. In the experiments, the researchers were able to show that the drug not only suppressed acute itch, but it effectively suppressed against the chronic itch. Mouse models that were treated with the drug were less inclined to scratch themselves and their skin changes healed more efficiently than the animal models administered the placebo. Most importantly, the drug did not cause and any adverse side-effects. "We are confident that the substance we've tested will also be effective in humans,” says Zeilhofer. “At the same time, the findings should be very valuable for veterinary medicine, since: Like humans, dogs also often suffer from the chronic itch. They too, therefore, stand to benefit from the approach."

 

Story Source: Nature Communications, University of Zurich

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 12, 2018
Drug Discovery
JUN 12, 2018
An Acetylcholine Blocker May Prevent Drug Addiction Relapse
It may sound like a paradox to produce a drug that is used to treat a drug addiction but scitnfcially speaking this is a logical possibility according to s...
JUL 24, 2018
Drug Discovery
JUL 24, 2018
The Chili Pepper Drug Aims To Combat Obesity
A new drug was recently developed based on capsaicin, the compound found in chili peppers that is responsible for their spicy properties, was seen to cause...
AUG 08, 2018
Drug Discovery
AUG 08, 2018
Old Drug Offers Novel Treatment For Hair Loss
According to researchers from The University of Manchester's Centre for Dermatology Research, a recent developed drug may serve as the key to treating ...
AUG 14, 2018
Drug Discovery
AUG 14, 2018
Anticancer Drugs Help Plants Fight Infection
Drugs used for cancer treatments may now help plants fight diseases. A study conducted at Washington State University (WSU), by two plant pathologists&mdas...
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Drug Reduced Recurrent Ventricular Tachycardia
A common drug used to treat chest pain, known as ranolazine and branded as Ranexa®, was found to be safe in a clinical study of more than 1,000 patient...
SEP 18, 2018
Drug Discovery
SEP 18, 2018
Clinical-Grade Drugs for Bone Diseases
According to a study published in Journal of Gerontology: Biological Sciences, a small molecule was discovered to play a role in bone formation, ultimately...
Loading Comments...